Biopharmaceuticals

Biopharmaceuticals
TradersPro Alerts

Adaptimmune Therapeutics plc (ADAP) – Buy Target: $9.53 – Sell Target: $11.45

Trade Setup Buy Target: $9.53 Sell Target: $11.45 Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States. The company’s specific peptide enhanced affinity receptor T-cell platform enables it to identify cancer targets. It is involved in developing ADP-A2M10 that is in […]

Read More
Biopharmaceuticals
Biotech
Daily Rundown
Earnings Reports
Economy
Payment Processors
Pharmaceuticals
Retailers
Specialty Retailers
Stock Picks
US Economy

Johnson & Johnson Inked A $1 Billion Deal With The U.S. Government For 100 Million Doses Of Its Coronavirus Vaccine Candidate

Plus, White House and Democratic negotiators made progress toward a deal on a new relief bill, ADP reported a sharp decrease in job creation in July, and Square’s earnings release was leaked ahead of schedule.

Read More
Biopharmaceuticals
Biotech
Penny Stocks
TradersPro Penny Stocks

Aileron Therapeutics, Inc. (ALRN)

Trade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day.   The stocks are pausing a trend either up or down, with a new bar over the prior day open or close.  These are high reward to risk stocks with the […]

Read More
Auto Industry
Biopharmaceuticals
China
Daily Rundown
Donald Trump
Earnings Reports
Economy
Gaming
Medical Devices
Pharmaceuticals
Social Media
Stock Picks
US Economy

Chinese State Media Call U.S. A “Rogue Country” Amid Conflict Over TikTok

Plus, democrat and republican negotiators made some progress on the next coronavirus relief bill, Ford’s Hackett is out as CEO, and Take-Two Interactive reported strong earnings results.

Read More
Amazon
Apple
Biopharmaceuticals
Daily Rundown
Earnings Reports
Economy
Energy Sector
Facebook
Google
Pharmaceuticals
Social Media
Stock Picks
Tech Stocks
US Economy

The U.S. Will Pay Sanofi & GlaxoSmithKline Up To $2.1 Billion For 100 Million Doses Of Their Coronavirus Vaccine Candidate

Plus, big tech stocks crushed earnings, $600-a-week unemployment benefits are set to expire with no agreement on a new stimulus bill in Congress, Merck is preparing to launch a large study of its experimental coronavirus treatment, and Pinterest is on the rise.

Read More
Biopharmaceuticals
Daily Rundown
Earnings Reports
Economic Trends
Economy
Health
Pharmaceuticals
Stock Picks
Tech Stocks
US Economy

U.S. GDP Dropped The Most On Record In The Second Quarter

Plus, jobless claims rose to 1.43 million last week, Johnson & Johnson said its coronavirus vaccine candidate protected moneys from the virus with a single shot, and big tech reports earnings after the bell.

Read More
Biopharmaceuticals
Biotech
Daily Rundown
Earnings Reports
Economy
Grocery
Retailers
Semiconductor
Stock Picks
Tech Stocks
US Economy

Moderna Just Dosed Its First Patients In Its Phase 3 Coronavirus Vaccine Trial

Plus, Republicans are expected to release the details of their coronavirus relief bill today, Hasbro shares are down after a 29% drop in revenue in the second quarter, and Target will be closed on Thanksgiving.

Read More
Biopharmaceuticals
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
Pharmaceuticals
Technical Analysis
Value Investing
Value Stocks

AZN is a COVID vaccine frontrunner – does that make it a stock you should buy?

The market seems intent on rebounding from last week’s break in bullish momentum, with the major indices at the beginning of a new week all moving higher. That looks like another sign that investors generally want to emphasize the positive and be hopeful. Indications over the weekend that the federal government could approve a second […]

Read More
Airlines
Athletic Apparel
Biopharmaceuticals
Biotech
China
Daily Rundown
Earnings Reports
Health
Social Media
Stock Picks
Tech Stocks
Trade War

Pfizer & BioNTech Just Landed A $1.95 billion Contract To Provide 100 Million Doses Of Its Coronavirus Vaccine

Plus, the U.S. ordered China to close its consulate in Houston, Nike announced a leadership shake-up, Slack filed a complaint against Microsoft with the European Commission, and United Airlines reported earnings.

Read More
Biopharmaceuticals
Biotech
Daily Rundown
Earnings Reports
Economy
Health
Investment Banks
Retailers
Specialty Retailers
Stock Picks
Tech Stocks
US Economy

Opko Health Shares Surge After Inking Deal To Provide Coronavirus Testing For The NFL

Plus, it’s looking unlikely Congress will pass another coronavirus relief bill before the end of July, IBM reported an earnings beat, eBay sold its classified ads unit, and Men’s Wearhouse-parent Tailored Brands is laying off 20% of its workforce and considering closing up to 500 stores.

Read More
Airlines
Amazon
Biopharmaceuticals
Biotech
Clean Energy
Crude Oil
Daily Rundown
Energy Sector
Oil
Retailers
Shale Oil
Stock Picks

Chevron Is Buying Noble Energy In Largest U.S. Energy Deal So Far This Year

Plus, AstraZeneca said its coronavirus vaccine developed with Oxford University showed a promising immune response in an early study, airline stocks are down after TSA said air travel is down for the first time since April, and Amazon is up after two bullish upgrades.

Read More
Biopharmaceuticals
One Hot Stock

Navidea Biopharmaceuticals, Inc. (NAVB) – Buy Price: $5.00 or better

Buy Price: $5.00 or better Sell Price: TradersPro Sell Signal Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The company operates in two segments, Diagnostic Substances and Therapeutic Development Programs.

Read More
Banking Sector
Biopharmaceuticals
Biotech
Daily Rundown
Earnings Reports
Economic Trends
Economy
Electric Vehicles
Investment Banks
Social Media
Stock Picks
Tech Stocks
US Economy

Twitter Shares Are Down After Hackers Attack High-Profile Users

Plus, jobless claims came in higher than 1 million for the seventeenth week in a row, security experts warned Russian hackers are trying to steal COVID-19 vaccine research, Morgan Stanley reported better-than-expected earnings, and Tesla shares are down after a report that its vehicle registrations were down by nearly half in the second quarter.

Read More
X